< Back to the News & Media page

  • NATROX® features at the New NHS Alliance Annual Conference at the King’s Fund in London

    In a communications initiative with New NHS Alliance & ITN Productions, Inotec AMD was featured in their campaign to promote “Healthy Communities, Healthy People’.

    https://itnproductions.wistia.com/medias/vnvlkkz8nf

    New NHS Alliance (www.nhsalliance.org) is a value-led movement of people and organisations who are committed to building a sustainable, community-based health service. It is expanding beyond its core roots in general practice and primary care to embrace people and organisations that can make a positive difference to people’s health and wellbeing. It is focused on heath inequalities and the practice of health creation. It wants to see primary care establish strong connections and collaborations with organisations that make a positive difference to people’s health and wellbeing and become a strong enabler of people-led health improvement.

    ITN Productions (www.itnproductions.co.uk) is ITN’s bespoke production hub producing creative and commercially valuable content for the corporate, commercial, broadcast and digital sectors. Industry News forms part of this offering and is a communications tool for leading industry bodies and national associations produced in a broadcast news programme format, including interviews, news-style items and sponsored editorial profiles.

    In a programme introduced by national newsreader Natasha Kaplinsky, ‘Healthy Communities, Healthy People’ which features Inotec AMD’s device NATROX® explores the change and transformation the health service in the UK is currently undergoing, by focusing on the people and organisations who are committed to building a sustainable, community-based health service.

    In an interview following release of the program, Consultant Vascular Surgeon Mr. Paul Hayes, Addenbrookes’ Vascular Surgery Department , Cambridge University Hospitals NHS Foundation Trust who is leading large scale trials of NATROX® said the device “may mark a paradigm shift in wound healing” and that “actively treating wounds instead of managing them saves money and maintains patient independence”.

    In a report published by NHS Diabetes diabetic foot ulcers and amputations cost the NHS around £650 million each year. Fiona Garnett, Assistant Director of Bedfordshire CCG commented that NATROX® provided innovation that “offers a solution to these difficult to manage people and a solution is much better than a long term treatment plan from a commissioning point of view as there is an end to it”

    About the NATROX system.

    The NATROX® system consists of the NATROX® Oxygen generator (OG) and the NATROX® Oxygen Delivery System (ODS) and is intended for hard to heal wounds such as leg ulcers, non-healing surgical and trauma wounds. Pure humidified oxygen is delivered to the wound surface in order to support the natural wound healing processes whilst the patient remains ambulatory.

    For more information, please visit http://inotecamd.com/.

    About Inotec AMD Ltd

    Inotec AMD is a specialist company in wound care, formed specifically to introduce a new technology to healthcare professionals around the world and promote faster and better healing to patients. Inotec AMD is a Cambridge Enterprise portfolio company backed by Amadeus Capital Partners.

    For more information, please visit http://inotecamd.com/.
    Company Contact
    Chad Bateman, CEO: chad.bateman@inotecamd.com